U.S. life sciences companies with ties overseas can be encouraged by a recent federal ruling that denied the request of foreign companies to conduct discovery in the United States in
Continue Reading Federal Court Denies Request of Foreign Companies to Conduct Discovery in the United States in Aid of a Foreign-Seated Arbitration

Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life
Continue Reading Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry

14756-0612-NY-gtMKG_PatentReform-3

Greenberg Traurig will be sponsoring two major Israel events this coming week.
The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies
Continue Reading Greenberg Traurig to Sponsor Two Major Israel Event

san-francisco_image

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco

A solar water heater on every Israeli rooftop
A solar water heater on every Israeli rooftop

Israel is a garden of inventiveness and Israelis have a strong tradition of contributing to technology and life sciences. Breathing the innovation when I lived there, I was privileged to test PrimeSense’s 3D camera, help bring Notal Vision’s tool to gauge macular degeneration to the United States, deliver a turn-key VoIP network in Nigeria and Zambia on behalf of VocalTec, license ecommerce and security software to dozens of Fortune 100 companies, watch knee surgery with miraculous tissue-repairing Regentis hydrogel, play with a gear box created from an Objet (now Stratasys) 3D printer, and negotiate sponsored research, patent licenses and clinical trials on behalf of emerging pharmaceutical companies.

Figuring out what gives rise to the “start-up nation” character, with wildly disproportionate foreign direct investment and numbers of translated books, cited academics, filed patents, Nasdaq companies, successful exits, and tuneful children’s songs, is a pervasive new-age question. Many answers have been floated, including its world-class research institutions, the very first technology transfer offices for commercialization of academic R&D, raw skills honed in one of the best-trained and most-sophisticated militaries, a culture of questioning, and a flood of ex-Soviet engineering talent over three decades. Naturally one can’t discount that there are real issues to be addressed too. Israelis have done it — from discerning security risks through synthesis of big data to making the desert bloom with fruit, vegetables, fish, and minerals.
Continue Reading Ingenuity in Israel’s Water